Promega

Madison, United States Founded: 1978 • Age: 48 yrs
Provider of genomics, protein analysis and expression, drug discovery, and genetic identification products

About Promega

Promega is a company based in Madison (United States) founded in 1978. The company has 17 employees. Promega operates in a competitive market with competitors including Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.

  • Headquarter Madison, United States
  • Employees 17
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website promega.in
  • Social LinkedIn X Facebook YouTube
  • Legal Name Promega Biotech India Private Limited
  • Date of Incorporation 25 Sep, 2013
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹76.63 Cr

    FY 2025 · +10% YoY

  • Net Profit
    ₹8.73 Cr

    FY 2025 · 11% margin

  • EBITDA
    ₹13.03 Cr

    FY 2025 · 17% margin

  • Investors
    NASA

    & 1 more

  • Employee Count
    17

Apps and channels of Promega

its YouTube channel Promega Corporation has 545 subscribers and 30 videos.

Promega Corporation
YouTube 545 subscribers 30 videos Science & Technology
Open channel

Videos from Promega

The most watched videos on Promega's YouTube channel, Promega Corporation (545 subscribers). Click a video to play it here.

Corporate Overview: Discover Promega
1.8K views
GloMax Instrument Remote Demo
1.3K views
RealTime-Glo™ Annexin V Apoptosis and Necrosis Assay
947 views
Promega GloMax with Eppendorf Move-It Adjustable Pipette
428 views

More on Promega Corporation.

Funding Insights of Promega

  • Total Rounds 4
  • First Round $1.03M

    (Sep 2007)

  • Investors Count 2

All 4 funding rounds of Promega with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2015–Grant––
Jan 2014–Grant––
Sep 2011$1.03MGrant––
Sep 2007$1.03MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in Promega

Promega has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NASA and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government space exploration and research services are provided.
1958nasa.govUnited States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
–europa.eu-
Premium access

Investor details for Promega

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Promega Biotech India Private Limited (Promega)

Promega Biotech India Private Limited is the primary company behind Promega. The board of Promega Biotech India Private Limited currently have 3 directors; the longest-serving is William Alderman Linton Iii, appointed in 2013. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
William Alderman Linton Iii
DIN 06635244
Director25 Sep 201313 yrsPromega Biotech India Private Limited
Rajnish Bharti
DIN 06872270
Whole-time director15 Dec 201411 yrs 9 moPromega Biotech India Private Limited
Daniel Lefleur Ghoca
DIN 09703522
Director22 Aug 20224 yrs 1 moPromega Biotech India Private Limited

Financials of Promega

Figures of Promega Biotech India Private Limited, the primary company behind Promega, for FY 2025. Revenue was ₹76.63 Cr (+10% year on year). Net profit was ₹8.73 Cr (11% margin). EBITDA was ₹13.03 Cr (17% margin). Revenue has grown at a compounded annual rate of +17% over three years and +21% over five years.

  • ₹76.63 CrRevenue · FY 2025 · +10% YoY
  • ₹8.73 CrNet profit · 11% margin
  • ₹13.03 CrEBITDA · 17% margin
  • ₹3.00 CrPaid-up capital
  • 17Employees (provident fund records)
  • +17%Revenue CAGR, 3 years
  • +21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Promega Biotech India Private Limited are on its company page.

Premium access

Detailed financial statements for Promega

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Promega

3 dated milestones of Promega across 37 years, from founding to its latest funding, stage changes and deals.

  1. Founded Promega is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Grant,.

Competitors of Promega

Promega operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abcam.com1998Cambridge, United Kingdom$78.8M405
Biological reagents and antibodies are developed for life science research.
quanterix.com2007Cambridge, United States$99.5M141
Assay kits for ultra-sensitive biomarker detection are developed.
biocare.net1997Concord, United States$85M161
Primary antibodies and instruments for immunohistochemistry are manufactured.
merckgroup.com1668Darmstadt, Germany–922
Merck is engaged in science and technology solutions globally.
biolifesolutions.com1987Bothell, United States–685
Tissue hypothermic storage and cryopreservation freeze media are developed.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
telesisbio.com2013San Diego, United States$25M–
Online platform offering life sciences reagents and kits
bio-rad.com1952Hercules, United States–10
Portfolio of products and services for life science research and clinical diagnostic markets
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
Premium access

Detailed competitors of Promega

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Promega

The website of Promega (promega.in) receives about 16.8K visits a month.

  • Monthly visits
    16.8K

    ▼ 27.7% vs previous month

Similar websites

Websites whose visitors overlap most with Promega. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
labome.com
100%
–#1,076,354View details
reactionbiology.com
100%
15.6K#1,617,891View details
promegaconnections.com
promegaconnections.com
97%
–#1,050,012–
cd-genomics.com
cd-genomics.com
93%
–#300,823–
fbae.org
fbae.org
93%
–#4,857,593–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 9 similar websites and full traffic analytics for Promega

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Promega

Premium access

Complete news archive for Promega

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Promega

10 companies that operate in the same segment as Promega (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Promega

Promega was founded in 1978 and raised its 1st funding round 29 years after it was founded.

Promega is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.

Promega has 17 employees.

The primary company behind Promega, Promega Biotech India Private Limited, reported revenue of ₹76.63 Cr for FY 2025, up 10% year on year.

Provider of genomics, protein analysis, and expression, drug discovery, and genetic identification products. The company claims to hold hundreds of patents in the areas of bioluminescence (engineered luciferases, luciferase reporter vectors, and luciferase substrates), cellular analysis, cell biology, and drug discovery. Their product portfolio includes assays, reagents, and kits to study cell health and energy metabolism, ADMET, cell signaling, immunodetection, products for DNA analysis and forensics, molecular diagnostics products, and more.

Promega's top competitors include Abcam, Biocare Medical and Sino Biological.

Promega has 2 investors. Key investors include NASA, and European Union.

Promega operates through Promega Biotech India Private Limited.

The legal entities of Promega currently have 3 directors, including Daniel Lefleur Ghoca, Rajnish Bharti, William Alderman Linton Iii.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available